Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Images_Of_Money/Flickr Creative Commons

The main drug industry trade group is launching a massive ad campaign to highlight the medical advances that have been created in the last few years — a counterstrike against the attacks they're facing over rising drug prices.

The Pharmaceutical Research and Manufacturers of America is pushing out a series of TV, print, digital and social ads, and there will be a series of events around the country to talk about medical innovation.

Why now: The industry is under fire from President Trump and many Democrats for rising drug prices, and PhRMA's leaders are concerned that the value of recent medical advances is being lost. PhRMA president and CEO Steve Ubl blames scandals around drug companies like Turing, Valeant and Mylan for driving the conversation through recent price hikes. But they say the campaign has been in the works for six months, and would have looked the same regardless of who was elected president.

We don't have a discussion today that addresses the value of the products, and it's driven by three bad actors. — Steve Ubl, PhRMA president and CEO

What you'll see: The ads will feature recent advances like personalized medicine — which finds treatments that are most likely to work on a given patient — and immunotherapy, which boosts the body's immune system to help it fight cancer.

What they'll spend: PhRMA spokesman Robert Zirkelbach wouldn't give exact numbers, but said it will be in the "high tens of millions of dollars every year" over the next four to five years.

What they want: Ubl says the drug industry wants to push for changes like "modernizing the FDA" to encourage medical innovation more easily, as well as changing the payment system to pay for the drugs with the most value.

What they would say to Trump: "I'm optimistic that we're going to find common ground," Ubl said. Asked whether he wanted to comment on Trump's proposal to let Medicare negotiate drug prices: "I'd rather not."

Go deeper

Axios-Ipsos poll: Trust in federal coronavirus response surges

Data: Axios/Ipsos survey; Chart: Danielle Alberti/Axios

Trust surged in the federal government since President Biden's inauguration when it comes to COVID-19 — but that's almost entirely because of Democrats gaining confidence, according to the latest installment of the Axios/Ipsos Coronavirus Index.

The big picture: Americans reported the biggest improvement in their mental and emotional health since our survey began last March, and the highest trust levels since April about the federal government providing them accurate virus information and looking out for their best interests.

7 hours ago - Politics & Policy

McConnell drops filibuster demand, paving way for power-sharing deal

Senate Majority Leader Chuck Schumer (R) and Minority Leader Mitch McConnell attend a joint session of Congress. Photo: Olivier Douliery/AFP via Getty Images

Senate Minority Leader Mitch McConnell has abandoned his demand that Democrats state, in writing, that they would not abandon the legislative filibuster.

Between the lines: McConnell was never going to agree to a 50-50 power sharing deal without putting up a fight over keeping the 60-vote threshold. But the minority leader ultimately caved after it became clear that delaying the organizing resolution was no longer feasible.

8 hours ago - Technology

Scoop: Google won't donate to members of Congress who voted against election results

Sen. Ted Cruz led the group of Republicans who opposed certifying the results. Photo: Stefani Reynolds/Pool/AFP via Getty Images

Google will not make contributions from its political action committee this cycle to any member of Congress who voted against certifying the results of the presidential election, following the deadly Capitol riot.

Why it matters: Several major businesses paused or pulled political donations following the events of Jan. 6, when pro-Trump rioters, riled up by former President Trump, stormed the Capitol on the day it was to certify the election results.